Red cell microparticles produced using high-pressure extrusion enhance both primary and secondary hemostasis

Area of Science:

• Hematology
• Biomedical Engineering

Background:

• Current excessive bleeding treatments have significant complications.
• Red blood cell-derived microparticles (RMPs) show promise as hemostatic agents with a good safety profile.
• The precise mechanism of RMPs in hemostasis requires further investigation.

Purpose of the Study:

• To elucidate the mechanism of action of RMPs in primary and secondary hemostasis.
• To evaluate the impact of RMPs on platelet aggregation and blood clotting.
• To determine if RMPs influence specific coagulation factor pathways.

Main Methods:

• Platelet aggregometry with inhibitors (eptifibatide, ticagrelor) was used to assess primary hemostasis.
• Thromboelastography with factor-deficient plasmas (VII, VIII, IX, XI, XII) was employed for secondary hemostasis evaluation.
• RMPs were prepared using high-pressure extrusion.

Main Results:

• RMPs significantly enhanced collagen-induced platelet aggregation.
• RMP effects on platelet aggregation were not significant in the presence of platelet inhibitors.
• RMPs significantly reduced clotting times in plasmas deficient in factors VII, VIII, IX, and XI, but not XII.

Conclusions:

• RMPs effectively enhance primary hemostasis.
• RMPs contribute to both pathways of secondary hemostasis.
• RMPs may act via platelet receptors and influence multiple coagulation factors.